Showing results (121-130 of 422) with videos related to
Sort By:
Pageof 43
The Netherlands Journal of Medicine|August 19, 2009
Cell-derived microvesicles and cancerF F van Doormaal, A Kleinjan, M Di Nisio, et al.The Netherlands Journal of Medicine|October 20, 2015
When do patients prefer a direct oral anticoagulant over a vitamin K antagonist?M S Boom, E M Berghuis, P T Nieuwkerk, et al.The Cochrane Database of Systematic Reviews|January 27, 2007
Treatment for superficial thrombophlebitis of the legM Di Nisio, S Middeldorp, I M WichersThe New England Journal of Medicine|November 29, 1990
Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosisH Heijboer, D P Brandjes, H R Büller, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|June 1, 1995
Easier monitoring of aminoglycoside therapy with once-daily dosing schedulesJ M Prins, R P Koopmans, H R Büller, et al.The Journal of Antimicrobial Chemotherapy|April 1, 1994
Once-daily gentamicin versus once-daily netilmicin in patients with serious infections--a randomized clinical trialJ M Prins, H R Büller, E J Kuijper, et al.The Netherlands Journal of Medicine|November 29, 2014
Anticoagulant treatment of cancer patients with pulmonary embolism in the real world. Actual use of low-molecular-weight heparin in cancerA Kleinjan, B A Hutten, M Di Nisio, et al.Pathophysiology of Haemostasis and Thrombosis|October 10, 2002
Treatment with vitamin K antagonists: frequency of indications and appropriateness of continuationJ F van Der Heijden, M G H Remkes, H R Büller, et al.Clinical Laboratory|December 8, 2000
Abrupt versus gradual withdrawal of vitamin K antagonist treatment in patients with venous thromboembolic disease: assessment of hypercoagulability and clinical outcomeM R de Groot, T L Njo, M van Marwijk Kooy, et al.Annals of Internal Medicine|February 15, 1992
Subcutaneous heparin compared with continuous intravenous heparin administration in the initial treatment of deep vein thrombosis. A meta-analysisD W Hommes, A Bura, L Mazzolai, et al.Pageof 43